SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-036933
Filing Date
2023-02-14
Accepted
2023-02-14 06:15:51
Documents
2
Group Members
BCIP LIFE SCIENCES ASSOCIATES, LPBCLS II EQUITY OPPORTUNITIES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d399033dsc13ga.htm SC 13G/A 83213
2 EX-99.A d399033dex99a.htm EX-99.A 12774
  Complete submission text file 0001193125-23-036933.txt   97626
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89552 | Film No.: 23621916
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Fund II, L.P. (Filed by) CIK: 0001773187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A